Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Hampel

Showing results (91-100 of 411) with videos related to

Pageof 42
Sort By:
Frontiers in Neuroscience|November 16, 2020
microRNA-Based Biomarkers in Alzheimer's Disease (AD)Yuhai Zhao, Vivian Jaber, Peter N Alexandrov, et al.
Statistical Methods in Medical Research|January 31, 2019
Reduction of recruitment costs in preclinical AD trials: validation of automatic pre-screening algorithm for brain amyloidosisManon Ansart, Stéphane Epelbaum, Geoffroy Gagliardi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 19, 2015
Mechanical stress related to brain atrophy in Alzheimer's diseaseMarcel Levy Nogueira, Olivier Lafitte, Jean-Marc Steyaert, et al.
Cerebral Cortex (New York, N.Y. : 1991)|November 13, 2004
Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomyJason P Lerch, Jens C Pruessner, Alex Zijdenbos, et al.
Plos One|May 5, 2012
White matter differences between healthy young ApoE4 carriers and non-carriers identified with tractography and support vector machinesLaurence O'Dwyer, Franck Lamberton, Silke Matura, et al.
Journal of Alzheimer'S Disease : JAD|April 2, 2014
Increased plasma TACE activity in subjects with mild cognitive impairment and patients with Alzheimer's diseaseQiying Sun, Harald Hampel, Kaj Blennow, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 24, 2024
Plasma pTau181 enhances the prediction of future clinical decline in amyloid-positive mild cognitive impairmentViswanath Devanarayan, Daniel A Llano, Yan Helen Hu, et al.
The Journal of Clinical Psychiatry|January 8, 2013
Long-term observation of a multicomponent cognitive intervention in mild cognitive impairmentVerena C Buschert, Ina Giegling, Stefan J Teipel, et al.
Progress in Neurobiology|August 23, 2011
Biomarkers for major depression and its delineation from neurodegenerative disordersBarbara Schneider, David Prvulovic, Viola Oertel-Knöchel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2022
Evaluation of major national dementia policies and health-care system preparedness for early medical action and implementationHarald Hampel, Andrea Vergallo, Takeshi Iwatsubo, et al.
Pageof 42

Showing results (91-100 of 411) with videos related to

Sort By:
Pageof 42
Frontiers in Neuroscience|November 16, 2020
microRNA-Based Biomarkers in Alzheimer's Disease (AD)Yuhai Zhao, Vivian Jaber, Peter N Alexandrov, et al.
Statistical Methods in Medical Research|January 31, 2019
Reduction of recruitment costs in preclinical AD trials: validation of automatic pre-screening algorithm for brain amyloidosisManon Ansart, Stéphane Epelbaum, Geoffroy Gagliardi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 19, 2015
Mechanical stress related to brain atrophy in Alzheimer's diseaseMarcel Levy Nogueira, Olivier Lafitte, Jean-Marc Steyaert, et al.
Cerebral Cortex (New York, N.Y. : 1991)|November 13, 2004
Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomyJason P Lerch, Jens C Pruessner, Alex Zijdenbos, et al.
Plos One|May 5, 2012
White matter differences between healthy young ApoE4 carriers and non-carriers identified with tractography and support vector machinesLaurence O'Dwyer, Franck Lamberton, Silke Matura, et al.
Journal of Alzheimer'S Disease : JAD|April 2, 2014
Increased plasma TACE activity in subjects with mild cognitive impairment and patients with Alzheimer's diseaseQiying Sun, Harald Hampel, Kaj Blennow, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 24, 2024
Plasma pTau181 enhances the prediction of future clinical decline in amyloid-positive mild cognitive impairmentViswanath Devanarayan, Daniel A Llano, Yan Helen Hu, et al.
The Journal of Clinical Psychiatry|January 8, 2013
Long-term observation of a multicomponent cognitive intervention in mild cognitive impairmentVerena C Buschert, Ina Giegling, Stefan J Teipel, et al.
Progress in Neurobiology|August 23, 2011
Biomarkers for major depression and its delineation from neurodegenerative disordersBarbara Schneider, David Prvulovic, Viola Oertel-Knöchel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2022
Evaluation of major national dementia policies and health-care system preparedness for early medical action and implementationHarald Hampel, Andrea Vergallo, Takeshi Iwatsubo, et al.
Pageof 42